Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Denmark Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20101
20121
20151
20171
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aalborg University Hospital2
European Organisation for Research and Treatment of Cancer - EORTC2
Eli Lilly and Company1
Incyte Corporation1
Jannie Bisgaard Stæhr1
Olfred Hansen1
Oslo University Hospital1
Vejle Hospital1
Vestre Viken Hospital Trust1
Åslaug Helland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms12
Carcinoma, Non-Small-Cell Lung6
Mesothelioma2
Melanoma1
Mesothelioma, Malignant1
Neoplasms1
Postoperative Pain1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.